Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Clinical trial NCT04305457 · TERMINATED

Trial details

NCT number: NCT04305457
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Infections Pneumonia, Viral Acute Respiratory Distress Syndrome

Start date: 2020-03-21
Primary completion: 2023-08-23
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.